Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06270199
PHASE2

Use of Mesenchymal Stem Cells in Pre-term Patients With Bronchopulmonary Dysplasia.

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

View on ClinicalTrials.gov

Summary

Bronchopulmonary dysplasia (BPD) is a disease that affects preterm newborn patients, preventing their lungs from developing properly. Allogeneic fetal stem mesenchymal cells from umbilical cord could reduce the prevalence of BPD in this patients.

Official title: Clinical Trial to Stablish the Security of Using Allogeneic Fetal Stem Mesenchymal Cells From Umbilical Cord, Expanded in Pre-term Patients Suffering of Bronchopulmonary Dysplasia.

Key Details

Gender

All

Age Range

1 Month - 28 Weeks

Study Type

INTERVENTIONAL

Enrollment

75

Start Date

2024-01-11

Completion Date

2026-12

Last Updated

2025-03-17

Healthy Volunteers

No

Interventions

BIOLOGICAL

Control

Standard treatment

BIOLOGICAL

Allogenic fetal mesenchymal stem cells from umbilical cord - three infusions

3 doses of 5 million MSC will be administered

BIOLOGICAL

Allogenic fetal mesenchymal stem cells from umbilical cord - six infusions

6 doses of 5 million MSC will be administered

Locations (7)

Hospital Quironsalud Madrid

Pozuelo de Alarcón, Madrid, Spain

Complejo Hospitalario La Coruña

A Coruña, Spain

Hospital Clínico San Carlos

Madrid, Spain

Hospital Universitario La Paz

Madrid, Spain

Hospital Universitario Carlos Haya

Málaga, Spain

Hospital Vírgen del Rocío

Seville, Spain

Hospital Universitario y Politécnico La Fe

Valencia, Spain